| Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
junctophilin 3 | 0.608 | 0.538 | 1.00 |
|
group | 0.010 | None | 1.000 | 1 | 0 | 1988 | 1988 | ||||||||
|
plasminogen activator, tissue type | 0.445 | 0.885 | 5.7E-05 |
|
group | 0.400 | None | 0.973 | 88 | 1 | 1989 | 2020 | ||||||||
|
lipoprotein(a) | 0.444 | 0.769 | 6.6E-89 |
|
group | 0.500 | None | 1.000 | 36 | 0 | 1989 | 2019 | ||||||||
|
cystatin C | 0.436 | 0.808 | 3.9E-03 |
|
group | 0.500 | limited | 1.000 | 11 | 0 | 1989 | 2020 | ||||||||
|
von Willebrand factor | 0.408 | 0.885 | 3.2E-25 |
|
group | 0.100 | None | 0.880 | 25 | 0 | 1990 | 2019 | ||||||||
|
plasminogen | 0.389 | 0.923 | 1.0E-02 |
|
group | 0.100 | None | 0.900 | 10 | 0 | 1991 | 2019 | ||||||||
|
SAC1 like phosphatidylinositide phosphatase | 0.682 | 0.500 | 0.70 |
|
group | 0.020 | None | 1.000 | 2 | 0 | 1992 | 1993 | ||||||||
|
ST8 alpha-N-acetyl-neuraminide alpha-2,8-sialyltransferase 4 | 0.546 | 0.846 | 4.0E-04 |
|
group | 0.020 | None | 1.000 | 2 | 0 | 1992 | 1993 | ||||||||
|
angiotensin I converting enzyme | 0.328 | 0.923 | 1.0E-37 |
|
group | 0.600 | None | 0.844 | 62 | 1 | 1994 | 2020 | ||||||||
|
protein C, inactivator of coagulation factors Va and VIIIa | 0.504 | 0.808 | 1.9E-05 |
|
group | 0.090 | None | 1.000 | 9 | 0 | 1994 | 2018 | ||||||||
|
hemoglobin subunit alpha 1 | 0.508 | 0.808 | 6.7E-03 |
|
group | 0.020 | None | 1.000 | 2 | 0 | 1994 | 2018 | ||||||||
|
hemoglobin subunit alpha 2 | 0.512 | 0.808 | 3.1E-03 |
|
group | 0.020 | None | 1.000 | 2 | 0 | 1994 | 2018 | ||||||||
|
protein S | 0.467 | 0.846 | 4.7E-04 |
|
group | 0.020 | None | 0.500 | 2 | 0 | 1994 | 2018 | ||||||||
|
5-hydroxytryptamine receptor 1D | 0.716 | 0.308 | 6.4E-04 |
|
group | 0.010 | None | 1.000 | 1 | 0 | 1994 | 1994 | ||||||||
|
chromosome 20 open reading frame 181 | 0.479 | 0.885 |
|
group | 0.100 | None | 0.957 | 115 | 0 | 1995 | 2020 | |||||||||
|
apolipoprotein E | 0.338 | 0.962 | 1.9E-03 |
|
group | 0.100 | None | 0.887 | 114 | 1 | 1995 | 2019 | ||||||||
|
coagulation factor II, thrombin | 0.415 | 0.885 | 1.1E-03 |
|
group | 0.500 | None | 0.946 | 29 | 4 | 1995 | 2020 | ||||||||
|
renin | 0.370 | 0.923 | 2.4E-07 |
|
group | 0.100 | None | 1.000 | 27 | 1 | 1995 | 2019 | ||||||||
|
coagulation factor V | 0.441 | 0.846 | 5.9E-15 |
|
group | 0.500 | None | 0.971 | 25 | 1 | 1995 | 2016 | ||||||||
|
interleukin 1 receptor antagonist | 0.373 | 0.923 | 3.1E-02 |
|
group | 0.400 | None | 0.944 | 16 | 1 | 1995 | 2018 | ||||||||
|
superoxide dismutase 2 | 0.379 | 0.923 | 0.15 |
|
group | 0.040 | None | 1.000 | 4 | 1 | 1995 | 2017 | ||||||||
|
SOD2 overlapping transcript 1 | 0.722 | 0.500 |
|
group | 0.010 | None | 1.000 | 1 | 0 | 1995 | 1995 | |||||||||
|
collagen type III alpha 1 chain | 0.477 | 0.808 | 1.00 |
|
group | 0.310 | strong | 1.000 | 1 | 3 | 1995 | 2014 | ||||||||
|
interleukin 6 | 0.248 | 0.962 | 0.32 |
|
group | 0.400 | None | 0.979 | 46 | 1 | 1996 | 2020 | ||||||||
|
notch receptor 3 | 0.435 | 0.808 | 0.41 |
|
group | 0.500 | strong | 0.973 | 36 | 9 | 1996 | 2020 |